These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7687222

  • 21. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
    Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D.
    J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
    Kobayashi S, Noh JY, Mukasa K, Kunii Y, Watanabe N, Matsumoto M, Ohye H, Suzuki M, Yoshihara A, Iwaku K, Sugino K, Ito K.
    Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
    Schut NH, Wiersinga WM, Van Oers MH.
    Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
    [Abstract] [Full Text] [Related]

  • 25. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 26. Delayed anithyroid drug-induced agranulocytosis.
    Mutharasan P, Oatis W, Kwaan H, Molitch M.
    Endocr Pract; 2012 May; 18(4):e69-72. PubMed ID: 22297058
    [Abstract] [Full Text] [Related]

  • 27. Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management.
    Vicente N, Cardoso L, Barros L, Carrilho F.
    Drugs R D; 2017 Mar; 17(1):91-96. PubMed ID: 28105610
    [Abstract] [Full Text] [Related]

  • 28. Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis.
    Andrès E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F.
    QJM; 2001 Aug; 94(8):423-8. PubMed ID: 11493719
    [Abstract] [Full Text] [Related]

  • 29. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis.
    Murakami Y, Sasaki I, Hiraiwa T, Arishima T, Ito M, Hanafusa T, Sakane S, Ohsawa N, Takamatsu J, Miyauchi A, Kuma K.
    Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577
    [Abstract] [Full Text] [Related]

  • 30. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J, Gabalec F, Svilias I, Horáček J.
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [Abstract] [Full Text] [Related]

  • 31. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
    Miyasaka Y, Yoshimura M, Tabata S, Shozu A, Nishikawa M, Iwasaka T, Inada M.
    Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
    [Abstract] [Full Text] [Related]

  • 32. Antithyroid drug-induced aplastic anemia.
    Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, Kaltsas G.
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [Abstract] [Full Text] [Related]

  • 33. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Límanová Z.
    Vnitr Lek; 2014 Oct; 60(10):815-6. PubMed ID: 25612339
    [No Abstract] [Full Text] [Related]

  • 34. [Agranulocytosis induced by synthetic antithyroid drugs: efficacy of hematopoietic growth factors].
    Genet P, Pulik M, Lionnet F, Bremont C.
    Ann Endocrinol (Paris); 1994 Oct; 55(1):39-42. PubMed ID: 7528487
    [Abstract] [Full Text] [Related]

  • 35. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
    Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, Niho Y.
    Arch Intern Med; 1993 Feb 22; 153(4):509-14. PubMed ID: 7679571
    [Abstract] [Full Text] [Related]

  • 36. Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease.
    Nakamura H, Ide A, Kudo T, Nishihara E, Ito M, Miyauchi A.
    Eur Thyroid J; 2016 Dec 22; 5(4):253-260. PubMed ID: 28101490
    [Abstract] [Full Text] [Related]

  • 37. Thyrotoxicosis and antithyroid drugs.
    Monakier D, Shilo S.
    Postgrad Med J; 1997 Jun 22; 73(860):335-6. PubMed ID: 9246331
    [No Abstract] [Full Text] [Related]

  • 38. The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis.
    Altunbas H, Yazicioglu G, Balci MK, Karayalçin U, Undar L.
    Int J Clin Pract; 1999 Jun 22; 53(5):396-7. PubMed ID: 10695110
    [Abstract] [Full Text] [Related]

  • 39. Antithyroid drug-induced agranulocytosis complicated by pneumococcal sepsis and upper airway obstruction.
    Ishimaru N, Ohnishi H, Nishiuma T, Doukuni R, Umezawa K, Oozone S, Kuramoto E, Yoshimura S, Kinami S.
    Intern Med; 2013 Jun 22; 52(20):2355-9. PubMed ID: 24126400
    [Abstract] [Full Text] [Related]

  • 40. Monitoring antithyroid therapy.
    Sobel R, Glick S.
    Arch Intern Med; 1993 Dec 27; 153(24):2797. PubMed ID: 7504914
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.